Skip to content

Effect of Different-Volume Fluid Resuscitation on Acute Pancreatitis: A Retrospective Cohort study

Effect of Different-Volume Fluid Resuscitation on Acute Pancreatitis: A Retrospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060600
Enrollment
Unknown
Registered
2022-06-05
Start date
2022-05-30
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis and Fluid Resuscitation

Interventions

Grouped based on the resuscitation volume:None

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of AP, which requires two of the following three criteria: (1) Typical abdominal pain; (2) Increase in serum amylase or lipase levels higher than three times the upper limit of normality; (3) Signs of AP in imaging (ultrasound\CT\MRI); 2. Patients 18 years or older; 3. Both male and female; 4. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Circulation: hypotension or shock (BP<90/60mmHg); 2. New York Heart Association class II heart failure (slight limitation of physical activity; fatigue, palpitations, or dyspnea with ordinal physical activity) or worse, or ejection fraction <50% in the last echocardiography); 3. Kidney disfunction: basal glomerular filtration rate <60mL/min per 1.73 m2) or need renal replacement therapy; 4. Liver disfunction or Decompensated cirrhosis (Childs class B or C); 5. Respiratory disfunction: respiratory failure(pO2<60mmHg or SpO2<90% or need mechanical ventilation); 6. Pregnant; 7. Clinical signs or symptoms of volume overload or heart failure at recruitment (dyspnea, peripheral edema, ascites); 8. Confirmed chronic pancreatitis or pancreatic malignant tumor.

Design outcomes

Primary

MeasureTime frame
SIRS and CRP levels of inflammatory indicators after the first 24 hours of fluid supplementation;

Secondary

MeasureTime frame
Length of hospitalization stay;Hematocrit, HCT;Blood urea nitrogen, BUN;Creatinine;PaO2/FiO2;Intraperitoneal pressure after fluid replacement;

Countries

Beijing

Contacts

Public ContactZhu Huadong

Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College

zhuhuadong1970@126.com+86 13910696435

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026